Immune Pharmaceuticals Inc (fka IMNPQ)

[Investor100]

Immune Pharmaceuticals Inc. (IMNP) Set to Announce Earnings on Thursday

mmune Pharmaceuticals Inc. (NASDAQ:IMNP) is scheduled to post its quarterly earnings results on Thursday, November 10th. Analysts expect Immune Pharmaceuticals to post earnings of ($0.14) per share for the quarter.

Immune Pharmaceuticals (NASDAQ:IMNP) last released its quarterly earnings results on Tuesday, August 16th. The biopharmaceutical company reported ($0.13) earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of ($0.13). On average, analysts expect Immune Pharmaceuticals to post $-0.58 EPS for the current fiscal year and $-0.17 EPS for the next fiscal year.

Shares of Immune Pharmaceuticals Inc. (NASDAQ:IMNP) traded down 2.9950% during trading on Tuesday, reaching $0.1749. The company had a trading volume of 2,103,717 shares. The company’s 50 day moving average is $0.25 and its 200-day moving average is $0.35. Immune Pharmaceuticals Inc. has a 1-year low of $0.17 and a 1-year high of $1.54. The stock’s market capitalization is $13.85 million.

Separately, FBR & Co reaffirmed a “buy” rating on shares of Immune Pharmaceuticals in a report on Sunday, September 18th.

Immune Pharmaceuticals Company Profile

Immune Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of targeted therapeutics in the fields of immuno-inflammation and immuno-oncology. The Company’s segment is acquiring, developing and commercializing prescription drug products.

http://www.com-unik.info/2016/11/08/immune-pharmaceuticals-inc-imnp-set-to-announce-earnings-on-thursday.html

investor 100